CLOV - February 7, 2021
CLOV was bought out from a Chamath SPAC, this ticker has been in the headlines recently for investigation by the SEC for upping prices for healthcare services. Look for Chamath tweets and news on the stock to produce movement. From a technical standpoint, if we see a breakout look for resistance around 14.30 and 18 before moving higher with a 6-week price target of 24. Support is around 11.30, invalidation occurs around 12.20. CLOV has earnings coming up on February 25th, 2021 pre-market.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。